Cargando…
Subthalamic Peak Beta Ratio Is Asymmetric in Glucocerebrosidase Mutation Carriers With Parkinson's Disease: A Pilot Study
Introduction: Up to 27% of individuals undergoing subthalamic nucleus deep brain stimulation (STN-DBS) have a genetic form of Parkinson's disease (PD). Glucocerebrosidase (GBA) mutation carriers, compared to sporadic PD, present with a more aggressive disease, less asymmetry, and fare worse on...
Autores principales: | David, Fabian J., Munoz, Miranda J., Shils, Jay L., Pauciulo, Michael W., Hale, Philip T., Nichols, William C., Afshari, Mitra, Sani, Sepehr, Verhagen Metman, Leo, Corcos, Daniel M., Pal, Gian D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514636/ https://www.ncbi.nlm.nih.gov/pubmed/34659089 http://dx.doi.org/10.3389/fneur.2021.723476 |
Ejemplares similares
-
The Effects of Subthalamic Nucleus Deep Brain Stimulation and Retention Delay on Memory-Guided Reaching Performance in People with Parkinson’s Disease
por: Trevarrow, Michael P., et al.
Publicado: (2023) -
Gait asymmetry in glucocerebrosidase mutation carriers with Parkinson’s disease
por: Gera, Anjali, et al.
Publicado: (2020) -
Borders of STN determined by MRI versus the electrophysiological STN. A comparison using intraoperative CT
por: Bus, Sander, et al.
Publicado: (2017) -
Using “Functional” Target Coordinates of the Subthalamic Nucleus to Assess the Indirect and Direct Methods of the Preoperative Planning: Do the Anatomical and Functional Targets Coincide?
por: Rabie, Ahmed, et al.
Publicado: (2016) -
Cognitive Functioning of Glucocerebrosidase (GBA) Non-manifesting Carriers
por: Moran, Eileen E., et al.
Publicado: (2021)